Skip to main content
Clinical Trials/NCT05909605
NCT05909605CompletedNot Applicable

Non-invasive Measurements of Arterial Pulses and Blood Pressure Using a Novel Ultrasound Patch

University of California, San Diego1 site in 1 country150 target enrollmentStarted: October 20, 2020Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
150
Locations
1
Primary Endpoint
Device comparison to standard monitoring (Sphygmomanometer)

Study Overview

Brief Summary

Blood pressure (BP) monitoring is essential for managing cardiovascular diseases. Arterial line (A-line), the clinical gold standard for BP monitoring, is too invasive for routine measurements. The sphygmomanometer, on the other hand, is non-invasive but captures only discrete values. The recently introduced conformal ultrasound sensor offers non-invasive and continuous monitoring of BP, which can potentially improve the quality of patient care, but its accuracy has yet to be thoroughly validated. Here the investigators are working to validate the accuracy of a redesigned ultrasound sensor with enhanced reliability in BP measurements at-home and in clinics even under different interventions.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to 90 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Are able to provide informed consent
  • Have at least one arm

Exclusion Criteria

  • Active cardiac arrhythmias
  • Any other unstable, active medical condition (i.e., cardiac arrythmia, uncontrolled diabetes, active heart failure, active liver failure)
  • Currently pregnant (this will be confirmed with a urine pregnancy test in women of childbearing potential)
  • Any large movements of the arms (e.g., chorea, dyskinesias, ballism), that in the investigators' opinion, would make it difficult to measure blood pressure using a standard blood pressure cuff
  • Any active skin infection or wound on the arm that would interfere with the devices used to measure blood pressure
  • Diagnosis of dementia

Outcomes

Primary Outcomes

Device comparison to standard monitoring (Sphygmomanometer)

Time Frame: 4 years

Clinical feasibility of the device accuracy of the non-invasive ultrasound blood pressure sensor in comparison to a sphygmomanometer on 90 participants in consulting room on orthostatic hypotension participants.

Device comparison to standard monitoring (A-line)

Time Frame: 3 years

Clinical feasibility of the ultrasound blood pressure sensor in comparison to an arterial line in the catheterization laboratory on 40 participants.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Sheng Xu

Associate Professor

University of California, San Diego

Study Sites (1)

Loading locations...

Similar Trials